2CG-12038-74547
1 vaccination
0 coded responses
6 check-ins
0 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 111 / NY
- Registered
- 2021-02-24
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Timeline
-
2021-02-24
Registered in v-safe
-
2021-02-24
Dose 1 — Pfizer-BioNTech
- 2021-02-24
-
2021-02-25
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-02-26
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness, NauseaAdult check-in
- 2021-02-27
-
2021-03-02
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-02
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-03-05
Health check-in — day 7, dose 1Feeling: Fair · Fatigue or tiredness · Be unable to workAdult check-in
- 2021-03-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-24 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-02 | priority 2/3 | |
| 2021-03-05 | priority 2/3 |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.